Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
February 11, 2014
Patent Application Number
12466222
Date Filed
May 14, 2009
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
The present invention relates to peptides, nucleic acids, and cells for use in the immunotherapy of cancer. The present invention furthermore relates to survivin-derived tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention specifically relates to three novel peptide sequences and variants thereof derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
